Top 4 Small-Cap Stocks In The Medical Laboratories & Research Industry With The Highest Revenue Estimates
Below are the top small-cap medical laboratories & research stocks on the NYSE and the NASDAQ in terms of revenue estimate for the current year.
Analysts expect Alere (NYSE: ALR) to post revenue of $2.78 billion for the year ending December, 2012. Alere had $303.15 million in total cash for the latest quarter.
ICON Public Limited Company (NASDAQ: ICLR) is likely to post revenue of $1.10 billion in the year ending December, 2012. ICON's trailing-twelve-month operating margin is 5.29%.
Bio-Reference Laboratories (NASDAQ: BRLI) may report revenue of $651.40 million in the current year. Bio-Reference Laboratories' PEG ratio is 0.90.
Alliance Healthcare Services (NYSE: AIQ) is expected to report revenue of $487.02 million for the year ending December, 2012. Alliance Healthcare's trailing-twelve-month ROA is 4.51%.
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.